<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01987401</url>
  </required_header>
  <id_info>
    <org_study_id>595Pilot</org_study_id>
    <nct_id>NCT01987401</nct_id>
  </id_info>
  <brief_title>Service and Health During the Iraq and Afghanistan Era</brief_title>
  <acronym>CSP #595 Pilot</acronym>
  <official_title>CSP #595Pilot - Respiratory Health and Deployment to Iraq and Afghanistan Pilot</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VA Office of Research and Development</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>VA Office of Research and Development</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of CSP #595, &quot;Service and Health During the Iraq and Afghanistan Era,&quot;
      is to characterize the impact of deployment to Iraq and Afghanistan on the respiratory health
      of Veterans. The purpose of the pilot study is to determine the willingness of Veterans who
      served during the Iraq and Afghanistan Era to provide health and military service
      information. This information will help us design a larger national study.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary objective of CSP #595, &quot;Respiratory Health and Deployment to Iraq and
      Afghanistan,&quot; is to assess the association of airborne exposures encountered during
      deployment with current measures of respiratory health among U.S. military Veterans who
      served in Iraq and Afghanistan.

      The purpose of the pilot study is to assess the feasibility and approach to conducting a
      large, multi-site Cooperative Studies Program (CSP) initiative to characterize the impact of
      deployment to Iraq and Afghanistan on the respiratory health of Veterans. The investigators
      will (a) determine the most efficient and feasible method for recruitment; (b) understand
      demographic, health-related, and military service-related factors influencing participation
      so that potential biases can be identified; and (c) demonstrate that the proposed individual
      exposure reconstruction techniques based on deployment history are feasible.

      Three aims are proposed: Aim 1: Using the Department of Defense (DoD) Defense Manpower Data
      Center (DMDC) master personnel roster, identify a representative sample of deployed Veterans
      who have served in Iraq and Afghanistan as well as a sample of non-deployed Veterans;
      identify the optimal methods for recruitment of participants to Phase 1 of data collection
      (mailed survey or telephone interview on self-reported health and military service history)
      and assess the willingness of Veterans to visit a nearby Veterans Health Administration (VHA)
      medical center to participate in Phase 2 in-person data collection, which includes more
      extensive self-reported health information, lifetime exposure ascertainment, and assessment
      of pulmonary function. Aim 2: Assess the Phase 2 participation rate of Veterans using VA
      Boston Healthcare System as a pilot study site. Aim 3: Using publically available exposure
      data and data from the DoD personnel file, demonstrate that the proposed individual exposure
      reconstruction techniques are feasible.

      The study is organized by the CSP Epidemiology Center program with the Seattle Epidemiologic
      Research and Information Center serving as the CSP coordinating center. The 2 participating
      sites are at the VA Boston Healthcare System and Durham VA Medical Center. The pilot study
      will provide information that will allow the planning of a national, large-scale health study
      to assess the residual effects of exposure to high levels of particulate matter while
      deployed. This will help inform VA health policy for Iraq and Afghanistan Veterans.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 2014</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">December 2015</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <target_duration>50 Years</target_duration>
  <primary_outcome>
    <measure>Participation Rates</measure>
    <time_frame>18 months</time_frame>
    <description>From the national sample, the investigators will compare participation rates for the mailed survey and telephone survey. Among a sample of Veterans living in the greater Boston area, the investigators will calculate participation rate for the in-person survey.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">1242</enrollment>
  <condition>Iraq and Afghanistan Era Veterans</condition>
  <arm_group>
    <arm_group_label>Iraq and Afghanistan Era Veterans</arm_group_label>
    <description>Veterans who served during the Iraq and Afghanistan Era</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Veterans who served during the Iraq and Afghanistan Era, without regard to actual
        deployment, identified from the Department of Defense (DoD) Defense Manpower Data Center
        (DMDC) master personnel roster of all persons serving during the time period of interest.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All competent, living men and women who served during the Iraq and Afghanistan Era and
             been discharged from the Army, Air Force, Marine Corps, or Navy are eligible to
             participate.

          -  Individuals in respective Guard and Reserve units are also eligible to participate.

          -  A Veteran is eligible without regard to deployment or combat status and without regard
             to current or past user status in the Veterans Health Administration.

        Exclusion Criteria:

          -  Veterans of the Coast Guard, including individuals in respective Guard and Reserve
             units, are not eligible to participate.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eric Garshick, MD</last_name>
    <role>Study Chair</role>
    <affiliation>VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rebecca B McNeil, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Durham VA Medical Center, Durham, NC</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Susan P Proctor, DSc</last_name>
    <role>Study Chair</role>
    <affiliation>VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02130</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Puget Sound Health Care System Seattle Division, Seattle, WA</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98108</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.seattle.eric.research.va.gov/</url>
    <description>Click here for more information about this study: CSP #595Pilot - Respiratory Health and Deployment to Iraq and Afghanistan Pilot</description>
  </link>
  <link>
    <url>http://www.research.va.gov/programs/csp/</url>
    <description>Click here for more information about this study: CSP #595Pilot - Respiratory Health and Deployment to Iraq and Afghanistan Pilot</description>
  </link>
  <verification_date>September 2018</verification_date>
  <study_first_submitted>November 12, 2013</study_first_submitted>
  <study_first_submitted_qc>November 12, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 19, 2013</study_first_posted>
  <results_first_submitted>May 23, 2017</results_first_submitted>
  <results_first_submitted_qc>September 10, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">September 12, 2018</results_first_posted>
  <last_update_submitted>September 10, 2018</last_update_submitted>
  <last_update_submitted_qc>September 10, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">September 12, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>pulmonary</keyword>
  <keyword>lung</keyword>
  <keyword>military and environmental exposures</keyword>
  <keyword>epidemiologic</keyword>
  <keyword>observational</keyword>
  <keyword>interview or questionnaire</keyword>
  <keyword>deployment related</keyword>
  <keyword>Enduring Freedom</keyword>
  <keyword>Iraqi Freedom</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Mailed Survey</title>
          <description>Participants who received the survey by mail.</description>
        </group>
        <group group_id="P2">
          <title>Telephone Survey</title>
          <description>Participants who received the survey by telephone.</description>
        </group>
        <group group_id="P3">
          <title>In-person Survey</title>
          <description>Participants who received survey in person.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="591"/>
                <participants group_id="P2" count="591"/>
                <participants group_id="P3" count="60"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="137"/>
                <participants group_id="P2" count="121"/>
                <participants group_id="P3" count="16"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="454"/>
                <participants group_id="P2" count="470"/>
                <participants group_id="P3" count="44"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Mail</title>
          <description>Received mail survey</description>
        </group>
        <group group_id="B2">
          <title>Phone</title>
          <description>Received phone survey</description>
        </group>
        <group group_id="B3">
          <title>In-Person</title>
          <description>Invited to in-person survey</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="591"/>
            <count group_id="B2" value="591"/>
            <count group_id="B3" value="60"/>
            <count group_id="B4" value="1242"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="38.2" spread="10.9"/>
                    <measurement group_id="B2" value="39.4" spread="11.5"/>
                    <measurement group_id="B3" value="36.7" spread="10.6"/>
                    <measurement group_id="B4" value="38.7" spread="11.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="87"/>
                    <measurement group_id="B2" value="93"/>
                    <measurement group_id="B3" value="8"/>
                    <measurement group_id="B4" value="188"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="504"/>
                    <measurement group_id="B2" value="498"/>
                    <measurement group_id="B3" value="52"/>
                    <measurement group_id="B4" value="1054"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="10"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="24"/>
                    <measurement group_id="B2" value="22"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="49"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="89"/>
                    <measurement group_id="B2" value="97"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="189"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="452"/>
                    <measurement group_id="B2" value="449"/>
                    <measurement group_id="B3" value="51"/>
                    <measurement group_id="B4" value="952"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="591"/>
                    <measurement group_id="B2" value="591"/>
                    <measurement group_id="B3" value="60"/>
                    <measurement group_id="B4" value="1242"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Participation Rates</title>
        <description>From the national sample, the investigators will compare participation rates for the mailed survey and telephone survey. Among a sample of Veterans living in the greater Boston area, the investigators will calculate participation rate for the in-person survey.</description>
        <time_frame>18 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Mailed Survey</title>
            <description>Participants who received the survey by mail.</description>
          </group>
          <group group_id="O2">
            <title>Telephone Survey</title>
            <description>Participants who received the survey by telephone.</description>
          </group>
          <group group_id="O3">
            <title>In-person Survey</title>
            <description>Participants who received survey in person.</description>
          </group>
        </group_list>
        <measure>
          <title>Participation Rates</title>
          <description>From the national sample, the investigators will compare participation rates for the mailed survey and telephone survey. Among a sample of Veterans living in the greater Boston area, the investigators will calculate participation rate for the in-person survey.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="591"/>
                <count group_id="O2" value="591"/>
                <count group_id="O3" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="137"/>
                    <measurement group_id="O2" value="121"/>
                    <measurement group_id="O3" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Mailed Survey</title>
          <description>Participants who received the survey by mail.</description>
        </group>
        <group group_id="E2">
          <title>Telephone Survey</title>
          <description>Participants who received the survey by telephone.</description>
        </group>
        <group group_id="E3">
          <title>In-person Survey</title>
          <description>Participants who received survey in person.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="591"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="591"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="591"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="591"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="591"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="591"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Nicholas L. Smith, Director of Seattle Cooperative Studies Program</name_or_title>
      <organization>Department of Veterans Affairs, Office of Research and Development</organization>
      <phone>2067642773</phone>
      <email>nicholas.smith@va.gov</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

